ww.sciencedirect.com
j o u r n a l o f p h a rm a c y r e s e a r c h 7 ( 2 0 1 3 ) 1 8 9e1 9 4
Available online at w
journal homepage: www.elsevier .com/locate/ jopr
Original Article
Abrogation of 5-flourouracil induced renal toxicity by beepropolis via targeting oxidative stress and inflammation inWistar rats
Summya Rashid a, Nemat Ali a, Sana Nafees a, Shiekh Tanveer Ahmad a,Syed Kazim Hasan a, Sarwat Sultana b,*aDepartment of Medical Elementology and Toxicology, Faculty of Science, Jamia Hamdard (Hamdard University), Hamdard Nagar,
New Delhi 110062, IndiabAssociate Professor, Section of Molecular Carcinogenesis and Chemoprevention, Department of Medical Elementology and Toxicology,
Faculty of Science, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi 110062, India
a r t i c l e i n f o
Article history:
Received 30 January 2013
Accepted 1 March 2013
Available online 26 March 2013
Keywords:
KIM-1
Nephrotoxicity
NFkB
Oxidative stress
TNFa
* Corresponding author. Tel.: þ91 11 2605468E-mail address: [email protected]
0974-6943/$ e see front matter Copyright ªhttp://dx.doi.org/10.1016/j.jopr.2013.03.003
a b s t r a c t
Background: 5-fluorouracil (5-FU) is a strong anticancer agent however its clinical use is
constrained because of its marked organ toxicity associated with increased oxidative stress
and inflammation. The present study was designed to investigate the protective effects of
bee propolis (BP), a naturally occurring bioflavonoid against 5-FU induced renal toxicity in
Wistar rats using biochemical, histopathological changes and expression levels of
inflammation.
Methodology: Wistar rats were subjected to concomitant pre and post-phylactic oral treat-
ment of BP (80 and 160 mg/kg b.wt.) against nephrotoxicity induced by i.p. injection of 5-FU
(75 mg/kg b.wt) and were sacrificed after 48 h. Nephrotoxicity was assessed by measuring
the level of serum creatinine, BUN, LDH, KIM-1 and TNFa. The level of anti-oxidant defense
enzymes of kidney tissue was also measured.
Results: Treatment with BP decreased the levels of serum toxicity markers significantly and
additionally induced anti-oxidant defense enzyme levels as well as decreased expression
of NFkB. Histopathological changes further confirmed the biochemical and immunohis-
tochemical results showing that 5-FU caused significant structural damage to kidneys like
tubular necrosis, renal lesions, glomerular congestion and dilated blood sinusoids were
also observed. All these features of 5-FU induced toxicity were reversed by co-
administration of BP.
Conclusion: Therefore, our study favors the view that BP may be a useful modulator in
alleviating 5-FU induced nephrotoxicity.
Copyright ª 2013, JPR Solutions; Published by Reed Elsevier India Pvt. Ltd. All rights
reserved.
5x5565, þ91 11 26054685x5566; fax: þ91 11 26059663.(S. Sultana).
2013, JPR Solutions; Published by Reed Elsevier India Pvt. Ltd. All rights reserved.
j o u rn a l o f p h a rma c y r e s e a r c h 7 ( 2 0 1 3 ) 1 8 9e1 9 4190
1. Introduction 2.2. Animals
5-FU is an antineoplastic agent, belongs to the group called
antimetabolites and functions as a pyrimidine analog, syn-
thesized by Heidelberg some 50 years ago.1 It has been used
extensively in the treatment of patients with breast, stom-
ach, colorectum, head and neck, genitourinary tracts, glau-
coma and skin cancer.2 Although it generates adequate
effect, it further exhibits severe toxicity and detrimental side
effects like leukopenia, diarrhea, stomatitis, alopecia,
mucositis,3 cardiotoxicity,4 nephrotoxicty and hepatotoxici-
ty.5 It results in DNA damage, proliferative inhibition and
apoptosis both in rapidly dividing cells including cancer cells
and some normal dividing cells.6 In this context, they often
induce side effects in cancer patients that severely limit their
activity.7 Concisely, chemotherapy commences with the
generation of oxidative stress and reactive oxygen species
(ROS) which act to directly damage cells and tissues. Sec-
ondly, the transcription factor, nuclear factor kappa B (NFkB)
is activated and leads to upregulation of many genes,
including those responsible for the production of proin-
flammatory cytokines8 like TNFa. Thus, chemicals with anti-
inflammatory/antioxidative properties and minimal side ef-
fects may serve as potential therapeutic agents for the
treatment. Free radical generation during treatment with 5-
FU, leading to lipid peroxidation and cell membrane dam-
age, could be one mechanism behind the toxic effects of 5-
FU.4
BP is a well known ancient folk medicine, an intricate
resinous hive product, and a blend of waxes, sugars and plant
exudates collected by bees from plants. Flavonoids, aromatic
acids, diterpenic acids and phenolic compounds appear to be
the principal components responsible for its biological activ-
ities. It is alleged to exhibit a broad spectrum of activities
including antibacterial, antifungal, antiviral, anti-
inflammatory, local-anesthetic, anti-oxidant, immune stim-
ulating, cytostatic and free radical scavenging activities.9
Recently, it is also being used in food and beverages to
improve health and prevent diseases such as inflammation,
heart disease, diabetes and cancer.10
To the best of our knowledge such an extensive study on
renal toxicity by 5-FU has been reported for the first time.
2. Materials and methods
2.1. Chemicals
Glutathione reductase, oxidized (GSSG) and reduced gluta-
thione, 1,2-dithio-bis-nitrobenzoic acid (DTNB), 1-chloro-2, 4-
dinitrobenzene, bovine serum albumin (BSA), oxidized and
reduced nicotinamide adenine dinucleotide phosphate
(NADP), (NADPH), flavine adenine dinucleotide, 2,6-
dichlorophenolindophenol, thiobarbituric acid (TBA), 5-FU
etc: were obtained from SigmaeAldrich, USA. Sodium hy-
droxide, ferric nitrate, trichloroacetic acid (TCA) and
perchloric acid (PCA) etc were purchased from CDH,
India. Plant extract was purchased from Saiba Industries,
Mumbai.
Male Wistar rats (150e200 g), 6e8 weeks old, were obtained
from the Central Animal House Facility of Hamdard Univer-
sity. Animals received humane care in accordance with the
guidelines of the Committee for the Purpose of Control and
Supervision of Experiments on Animals (CPCSEA),Govern-
ment of India, and prior permission was sought from the
Institutional Animal Ethics Committee (IAEC No: 173/CPCSEA,
28 January 2000).
2.3. Treatment protocol
Rats were randomly divided into five groups of six rats each.
Group I served as control and received water for 28 days and
0.9% saline intraperitoneally (i.p.) on day 25th, 26th. Group II
received i.p. injections of 5-FU (75 mg/kg b.wt.) on 25th and
26th day. Groups III and IVwere treatedwith an oral dose of BP
80 mg/kg b.wt. (D1) and 160 mg/kg b.wt. (D2), respectively, for
28 days and i.p. injections of 5-FU (75 mg/kg b.wt.) were
administered on 25th and 26th day. Group V received only D2
(160 mg/kg b.wt.) of BP for 28 days. On the 28th day, the rats
were sacrificed by cervical dislocation, blood was drawn for
serum parameters and kidneys were taken after perfusion for
examination of various biochemical, immunohistochemical
and histopathological parameters.
2.4. Biochemical estimation
Assay for catalase (CAT), lipid peroxidation (LPO), Superoxide
dismustase (SOD), reduced glutathione (GR), glutathione
peroxidase (GPx), glutathione reductase (GR), Blood Urea Ni-
trogen (BUN), Creatinine, lactate dehydrogenase (LDH) and
protein estimation was done by the method as described by
Rehman et al.11
2.5. Assay for tumor necrosis factor (TNFa) and KIM-1(Kidney injury molecule-1)
The level of TNF-a was quantitated using an ELISA based kit
(eBioscience, Inc., San Diego., USA) and KIM-1 (RAT KIM-1
ELISA KIT, Adipo Bioscience, Inc, USA) following instructions
of the manufacturer.
2.6. Immunohistochemistry
Kidney sections on polylysine coated slides obtained were
fixed in neutral buffered formalin, and embedded in paraffin
andwere treated for NFkB antibody for immunohistochemical
analysis. The procedure was processed according to the
manufacturer’s protocol recommended for NFkB immuno-
histochemistry with slight modifications.
2.7. Histopathological examination
The kidneys were quickly removed after sacrifice and pre-
served in 10% neutral buffered formalin for histopathological
processing. The kidneys were embedded in paraffin wax and
longitudinally sectioned with a microtome. Hematoxylin and
GPX
(mm
olNADPH
Oxidized/m
in/m
gpro
tein)
181.85�
14.33
80.2
�7.07***
135.99�
10.77#
153.74�
9.58###
172.39�
13.64
ntfrom
gro
upII
(#P<
0.05),
j o u r n a l o f p h a rm a c y r e s e a r c h 7 ( 2 0 1 3 ) 1 8 9e1 9 4 191
eosin staining of the sectionswas observed under an Olympus
microscope.
2.8. Statistical analysis
Differences between groups were analyzed using analysis of
variance (ANOVA) followed by Dunnet’s multiple compari-
sons test. All data points are presented as the treatment
groups’ mean � standard error (SE).
SOD,LPO,GSH,GRandGPxon5-FU
adm
inistrationin
kidneyofW
istarra
ts.
(nm
olH
2O2co
nsu
med
/min/m
gpro
tein)
SOD
(units/m
gofpro
tein)
LPO
(nm
ol
MDA
form
ed/h
pergtiss
ue)
GSH
(mm
ol
CDNBConjugate
form
ed/g
tiss
ue)
GR(mm
ol
NADPH
Oxidized
/min/m
gpro
tein)
37.1
�1.67
30.33�
2.14
9.32�
0.88
0.85�
0.03
199.86�
5.6
14.85�
1.49***
16.54�
1.31***
33.38�
3.11***
0.28�
0.07***
110.95�
6.3***
17.71�
3.87ns
21.59�
0.92ns
23.75�
1.12#
0.606�
0.04#
137.97�
8.67ns
29.30�
3.30##
24.55�
1.21##
18.68�
2.27##
0.72�
0.09##
155.95�
7.02##
32.48�
3.10
26.61�
1.35
9.81�
1.07
0.84�
0.02
194.57�
9.31
nim
als
pergro
up.Resu
ltsobtainedare
significa
ntlydifferentfrom
gro
upI(***P<
0.001).Resu
ltsobtainedare
significa
ntlydiffere
(###P<
0.00).
3. Results
3.1. Effect of 5-FU and BP on enzymic, non-enzymicarmory and MDA
Prophylaxis with BP showed an increase in GSH, GPx, GR, CAT,
SOD (ns- not significant, #P < 0.05, ##P < 0.01 and ###P < 0.001)
levels when compared with group II (***P < 0.001) and a
decrease in MDA formation dose dependently (#P < 0.05 and##P < 0.01) when compared with group II (Table 1).
3.2. Effect of 5-FU and BP treatment on the level ofserum toxicity markers
Creatinine, BUN, LDH, TNFa and KIM-1 were significantly
elevated in group II (***P < 0.001) (Table 2). Prophylactic
treatment prevented 5-FU induced elevation in all the
mentioned parameters (ns- not significant, #P < 0.05,##P < 0.01) dose dependently as compared to control.
3.3. Effect of BP on NFkB expression in 5-FU treated ratkidney
The immunohistochemical evaluation showed more intense
expression of NFkB in rats subjected to 5-FU compared with
control (Fig. 1). There was considerably moderate protein
expression of NFkB in group III as compared to II. However,
group IV showed considerably very poor or no staining.
3.4. Effect of BP against 5-FU induced histopathologicalalterations in kidney
The histology report showed that BP significantly prevented
disruption of the normal renal architecture that was distorted
by 5-FU administration in which necrosis, interstitial hemor-
rhages, glomerular atrophy and blood sinusoids could be seen
(Fig. 2).
Table
1e
Resu
ltsofBPonCAT,
Treatm
entregim
en
pergro
up
CAT
Gro
upI(control)
Gro
upII(only
5-FU)
Gro
upIII(5-FU
þBPD1)
Gro
upIV
(5-FU
þBPD2)
Gro
upV
(only
BPD2)
Resu
ltsreprese
ntmean
�SEofsixa
(##P<
0.01),(n
sP¼
notsignifica
nt)
and
4. Discussion
Although several studies have been carried out to elucidate
the molecular mechanism that causes 5-FU induced nephro-
toxicity. However factors responsible for this are not fully
understood. Chemotherapy instigates DNA and non-DNA
damage along with the production of reactive oxygen spe-
cies (ROS) or reactive nitrogen species (RNS) and a variety of
inflammatory responses. Thus, chemicals with anti-
inflammatory/antioxidative properties and minimal side
Table 2 e Results of modulatory effect of BP on BUN, creatinine, LDH, TNFa and KIM-1 on 5-FU induced renal toxicity.
Treatment regimenper group
BUN (IU/L) Creatinine(IU/L)
LDH(n mol NADHoxidized/min/mg protein)
TNF-a (pg/ml) KIM-1(mg/gserum Cr)
Group I (control) 19.75 � 0.34 0.98 � 0.07 190.96 � 18.78 160.66 � 8.4 18.427 � 2.87
Group II (only 5-FU) 34.01 � 1.34*** 2.8 � 0.09*** 356.01 � 13.78*** 364.33 � 11.62*** 110.15 � 7.684***
Group III(5-FU þ BP D1) 26.47 � 0.71# 2.3 � 0.25ns 266.08 � 28.56# 315.33 � 10.17# 83.693 � 4.472#
Group IV(5-FU þ BP D2) 23.05 � 0.85## 1.7 � 0.04## 224.82 � 17.41## 297.66 � 8.81## 69.05 � 5.11##
Group V (only BP D2) 20.99 � 0.72 1.1 � 0.02 189.38 � 9.54 154 � 4.72 25.74 � 4.56
Results representmean� SE of six animals per group. Results obtained are significantly different from group I (***P< 0.001). Results obtained are
significantly different from group II (#P < 0.05), (##P < 0.01), (nsP ¼ not significant) and (###P < 0.00).
j o u rn a l o f p h a rma c y r e s e a r c h 7 ( 2 0 1 3 ) 1 8 9e1 9 4192
effects which could be incorporated as dietary agents may
serve as potential therapeutic agents for the treatment of
chemotherapy induced organ toxicity and are worthy of
detailed investigation.12 Several anticancer drugs, including 5-
FU and oxaliplatin, have been shown to increase intracellular
concentration of ROS, and inhibition of drug induced increase
in ROS concentrations partly reverse the cytotoxicity of these
agents.13 In the present study 5-FU treated rats demonstrate
augmented level of MDA, lipid peroxidationmarker compared
to control rats as reported by Ali.5 The ingestion of BP to 5-FU
treated rats considerably decreased MDA compared to group
II. Since the most essential pharmacologically active compo-
nents in BP are flavonoids and various phenolics which have
free radical scavenging power and thus protecting lipids from
being oxidized during oxidative damage.14 SOD forms the
primary shield against superoxide as it converts reactive su-
peroxide radicals to H2O2 and H2O. However, Glutathione
peroxidase (GPx) converts H2O2 and other ROS to H2O2 and
H2O. Catalase (CAT) catalyzes H2O2 to H2O and O2. In the
present study, the activities of SOD, GPx, GR and CAT were
significantly decreased in group II as compared to I. BP
administration to 5-FU treated groups improved these
Fig. 1 e Representative photomicrograph of NFkB protein expre
group showing very less staining, (B) NFkB expression in group
expression in group III showing very less staining as compared
enzymes, may be by scavenging singlet oxygen, superoxide
anions, peroxy radicals, OH-. GSH is a tripeptide which de-
toxifies ROS efficiently, gets depleted after 5-FU injection and
gets replenished by BP prophylaxis. Present work supports
Bhadauria.15 BUN, creatinine and LDH levels were augmented
in 5-FU group.5 In contrast, BP ameliorated their levels as
compared to group II. This is an indicator of the possible
nephroprotective efficacy offered by BP against 5-FU toxicity
indicating that BP has a tendency to thwart damage and
inhibit the seepage of enzymes through cellular membranes.
KIM-1 is a transmembrane tubular protein and is barely
discernible in normal kidneys, nevertheless, it is strikingly
induced in acute kidney injury and chronic kidney disease. It
is a sensitive and explicit marker of kidney injury as well as
predictor of prognosis as supported by Huo.16 In our study,
KIM-1 levels were markedly increased in group II. Although,
prophylactic treatment of BP suppressed abnormal levels of
KIM-1.
TNF-a is a proinflammatory cytokine which plays a
widespread role in many biological processes like cell death,
growth, development, oncogenesis and immune responses.
Present study also illustrated that 5-FU administration
ssion of rat kidney. (A) NFkB protein expression in control
II showing highly intense and positive staining, (C) NFkB
to group II (D) very less staining almost similar to control IV.
Fig. 2 e (AeE) Histopathological examination of rat kidney 340. (A) Normal histology of kidney (B) disruption of the normal
renal architecture by 5-FU administration was observed as shown by arrows. (C & D) Treatment with BP showed protective
changes in the glomeruli and tubules and the morphology of tubular epithelial cells on higher dose of BP (E) kidney showed
normal histology of almost similar to control group.
j o u r n a l o f p h a rm a c y r e s e a r c h 7 ( 2 0 1 3 ) 1 8 9e1 9 4 193
significantly increases TNF-a. It has been reported that
oxidative stress may also commence or augment inflamma-
tion via upregulation of various genes implicated in the in-
flammatory mechanisms. NFkB is one of them, whose
activation results in the upregulation of proinflammatory
cytokines. Oxygen free radicals and TNF-a could activate
NFkB which is a redox sensitive transcription factor, which in
turn stimulates the successive inflammatory cascade. How-
ever mechanistic pathway of NFkB signaling and its correla-
tion with oxidative stress is not fully clear. Although it has
been reported that the use of anti-oxidants and ROS scav-
engers like cysteine, NAC, thiols, & green tea polyphenols can
check the activation of NFkB by oxidative stress .The above
findings show that ROS plays an active role in TNF-a release
and NFkB activation. Our present study gives the supporting
evidence for the induction and activation of NFkB in group II.
Present work support Tung et al and Khan et al work.17,18 It
was found that NFkB expression and TNF-a release was
attenuated substantially by BP treatment thus reducing in-
flammatory response implicated in 5-FU induced renal
toxicity.
To summarize we found that BP ameliorated molecular
targets implicated in the toxicity of 5-FU administration in
animalmodel. Hence further investigations need to be done to
be made useful for human use.
Funding
The authors are thankful to UGC, New Delhi India under SAP
of Departmental Research Support II and BSR for the award of
project to carry out the study.
Conflicts of interest
All authors have none to declare.
r e f e r e n c e s
1. Seto Y, Nagawa H, Mori M, Tsuruo T, Muto T. Effect of 5-fluorouracil on gastrointestinal carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in rats. Dig Dis Sci.1999;44(1):75e78.
2. Shirasaka T, Shimamoto Y, Fukushima M. Inhibition byoxonic acid of gastrointestinal toxicity of 5-fluorouracilwithout loss of its antitumor activity in rats. Cancer Res.1993;53(17):4004e4009.
3. Bathina JD, Yusuf SW. 5-Fluorouracil-induced coronaryvasospasm. J Cardiovasc Med. 2010;11(4):281e284.
j o u rn a l o f p h a rma c y r e s e a r c h 7 ( 2 0 1 3 ) 1 8 9e1 9 4194
4. Kinhult S, Albertsson M, Eskilsson J, Cwikiel M. Effects ofprobucol on endothelial damage by 5-fluorouracil. Acta Oncol.2003;42(4):304e308.
5. Ali Nora El-Hoseany M. Protective effect of captopril against5-fluorouracil-induced hepato and nephrotoxicity in malealbino rats. J Am Sci. 2012;8(2).
6. Xian CJ, Howarth GS, Cool JC, Foster BK. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-Ipretreatment on growth plate cartilage and metaphysealbone in rats. Bone. 2004;35(3):739e749.
7. Lamberti Monica, Porto Stefania, Marra Monica, et al. 5-Fluorouracil induces apoptosis in rat cardiocytes throughintracellular oxidative stress. J Exp Clin Cancer Res. 2012;31:60.
8. Bowen JM, Gibson RJ, Cummins AG, Keefe DM. Intestinalmucositis: the role of the Bcl-2 family, p53 and caspases inchemotherapy-induced damage. Support Care Cancer.2006;14(7):713e731.
9. Lahouel Mesbah, Boutabet Kheira, Kebsa Wided,Alyane Mohamed. Polyphenolic fractions of Algerian propolisreverses doxorubicin induced acute renal oxidative stress. AfrJ Pharm Pharmacol. 2010;4(10):712e720.
10. Ozkul Y, Silici S, Ero�glu E. The anticarcinogenic effect ofpropolis in human lymphocytes culture. Phytomedicine.2005;12(10):742e747.
11. Rehman Muneeb U, Tahir Mir, Khan Abdul Quaiyoom, et al.Methanolic extract of Bacopa monnieri protects against KBrO3-induced renal damage in Wistar rats by restoring antioxidantenzyme activities and suppressing inflammation andapoptosis. JPR. 2012;5(11):5231e5238.
12. Huang TY, Chu HC, Lin YL, et al. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mousemodel. Biochem Biophys Res Commun. 2009;389(4):634e639.
13. Koc S, Kıyıcı H, So�gut E, Eyibilen A, Ekici A, Salman N. Effect ofpentoxifylline and 5-fluorouracil/triamcinolone onlaryngotracheal stenosis developing as a complication oftracheostomy: study in rats. Eur Arch Otorhinolaryngol.2012;269(7):1813e1820.
14. Mohammadzadeh Shiva, Sharriatpanahi Mohammad,Hamedi Manoochehr, Amanzadeh Yaghoub, SadatEbrahimi Seyed Esmaeil, Ostad Seyed Nasser. Antioxidantpowerof Iranianpropolis extract.FoodChem. 2007;103:729e733.
15. Bhadauria M. Combined treatment of HEDTA and propolisprevents aluminum induced toxicity in rats. Food ChemToxicol. 2012;50(7):2487e2495.
16. Huo Wenqian, Zhang Keqin, Nie Zhilin, Li Qiansheng,Jin Fengshuo. Kidney injury molecule-1 (KIM-1): a novelkidney-specific injury molecule playing potentialdouble-edged functions in kidney injury. Transplant Rev. 2010;24:143e146.
17. Tung David, Cheung Peter H, Tudor Gregory, Booth Catherine,Saha Saurabh. In vivo effects of immunomodulators in amurine model of fluorouracil-induced mucositis. Curr TherapRes. 2011;72(6):262e272.
18. Khan Abdul Quaiyoom, Nafees Sana, Sultana Sarwat. Perillylalcohol protects against ethanol induced acute liver injury inWistar rats by inhibiting oxidative stress, NFkB activation andproinflammatory cytokine production. Toxicology. 2011;279:108e114.